NCT05384015
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05384015
Title Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)
Acronym PEERS
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion GECP
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital General Universitario de Alicante Alicante Alicante 03010 Spain Details
ICO Badalona, Hospital Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
Hospital Universitari Vall d' Hebron Barcelona Barcelona 08035 Spain Details
Hospital Clínic De Barcelona Barcelona Barcelona 08036 Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona Barcelona 08041 Spain Details
Hospital Parc Taulí Barcelona Barcelona 08208 Spain Details
Hospital De Basurto Bilbao Bilbao 48013 Spain Details
ICO Girona, Hospital Josep Trueta Girona Girona 17007 Spain Details
Hospitalario Universitario A Coruña A Coruña La Coruña 15006 Spain Details
Hospital Universitario Lucus Augusti Lugo Lugo 27003 Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid Madrid 28040 Spain Details
Hospital 12 De Octubre Madrid Madrid 28041 Spain Details
Hospital Universitario Puerta de Hierro Majadahonda Madrid 28222 Spain Details
Hospital Universitario Regional de Málaga Málaga Málaga 29010 Spain Details
Hospital Son Espases Palma de Mallorca Palma de Mallorca 07120 Spain Details
Complejo Hospitalario de Navarra Pamplona Pamplona 31008 Spain Details
Hospital Clínico de Valencia Valencia Valencia 46010 Spain Details
Hospital General Universitario de Valencia Valencia Valencia 46014 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field